tiprankstipranks
Advertisement
Advertisement

SNYNF Stock Latest News

Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
The FlyDianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
1d ago
SNY
DNTH
Sanofi’s ARAVA Safety Study in Saudi Arabia: What Investors Should Know Now
PremiumCompany Announcements
Sanofi’s ARAVA Safety Study in Saudi Arabia: What Investors Should Know Now
3d ago
SNYNF
Dianthus price target raised to $132 from $110 at Jefferies
PremiumThe Fly
Dianthus price target raised to $132 from $110 at Jefferies
3d ago
SNY
DNTH
Sanofi Ends Phase 2 Amlitelimab Alopecia Trial, Nudging Investor Expectations
PremiumCompany Announcements
Sanofi Ends Phase 2 Amlitelimab Alopecia Trial, Nudging Investor Expectations
4d ago
SNYNF
Midday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
PremiumThe Fly
Midday Fly By: SpaceX IPO oversubscribed, Chewy reports in-line Q1
4d ago
F
SN
Buy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
PremiumThe FlyBuy Dianthus on weakness amid ‘overdone’ selloff, says H.C. Wainwright
4d ago
SNY
DNTH
Video: Cracker Barrel advances after beat and raise report
Premium
The Fly
Video: Cracker Barrel advances after beat and raise report
4d ago
SNY
CBRL
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
Premium
The Fly
Stifel says Sanofi stopping MOBILIZE study potentially positive for Dianthus
4d ago
SNY
DNTH
Dianthus sinks after Sanofi halts CIDP Phase 3 study
PremiumThe Fly
Dianthus sinks after Sanofi halts CIDP Phase 3 study
4d ago
SNY
DNTH
Sanofi to halt riliprubart Mobilize phase 3 study
PremiumThe Fly
Sanofi to halt riliprubart Mobilize phase 3 study
4d ago
SNY
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
9d ago
AZN
BMY
RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
PremiumCompany Announcements
RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
10d ago
REGN
Snowflake says Sanofi selects Snowflake Cortex AI for drug development
PremiumThe FlySnowflake says Sanofi selects Snowflake Cortex AI for drug development
12d ago
SNY
SNOW
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
12d ago
AZN
BMY
Sanofi’s SAR442257 Trial Update: Early Oncology Progress With Measured Investor Upside
Premium
Company Announcements
Sanofi’s SAR442257 Trial Update: Early Oncology Progress With Measured Investor Upside
16d ago
SNYNF
Sanofi announces FDA grants priority review to venglustat new drug application
PremiumThe Fly
Sanofi announces FDA grants priority review to venglustat new drug application
17d ago
SNY
Trump Trade: Trump announces expansion of TrumpRx.gov
PremiumThe Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
26d ago
AZN
BMY
Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint
PremiumThe Fly
Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint
26d ago
SNY
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
PremiumThe Fly
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
27d ago
AZN
BMY
Regeneron price target lowered to $707 from $762 at RBC Capital
PremiumThe FlyRegeneron price target lowered to $707 from $762 at RBC Capital
27d ago
SNY
REGN
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
29d ago
AZN
BMY
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
Premium
Company Announcements
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
30d ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >